Soft Tissue Defect
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Geistlich PharmaSwitzerland - Root
1 programSoft tissue flap + Connective Tissue GraftN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Geistlich PharmaSoft tissue flap + Connective Tissue Graft
Clinical Trials (1)
Total enrollment: 60 patients across 1 trials
Evaluation of Geistlich Fibro-Gide® in Comparison to CTG for the Treatment Around Implants
Start: Aug 2018Est. completion: Dec 202560 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space